Sven Lee
Geen lopende functies
Profiel
Sven Lee worked as a Director of Business Development at Johnson & Johnson Ltd.
and Crucell UK Ltd.
He then worked as the Chief Business Officer at Abzena Ltd.
from 2016 to 2022.
Mr. Lee received his undergraduate degree from Lake Forest College.
Eerdere bekende functies van Sven Lee
| Bedrijven | Functie | Einde |
|---|---|---|
| ABZENA PLC | Corporate Officer/Principal | 01-11-2022 |
Johnson & Johnson Ltd.
 Johnson & Johnson Ltd. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Ltd. is a British company that manufactures health care products. The company is based in Maidenhead, UK. Founded in 1987. | Corporate Officer/Principal | - |
Crucell UK Ltd.
 Crucell UK Ltd. Pharmaceuticals: OtherHealth Technology Crucell UK Ltd. develops, produces, and markets vaccines and antibodies to combat infectious diseases. The private company is based in Bradford, UK. | Corporate Officer/Principal | - |
Opleiding van Sven Lee
| Lake Forest College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Johnson & Johnson Ltd.
Johnson & Johnson Ltd. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Ltd. is a British company that manufactures health care products. The company is based in Maidenhead, UK. Founded in 1987. | Consumer Non-Durables |
Crucell UK Ltd.
Crucell UK Ltd. Pharmaceuticals: OtherHealth Technology Crucell UK Ltd. develops, produces, and markets vaccines and antibodies to combat infectious diseases. The private company is based in Bradford, UK. | Health Technology |
Abzena Ltd.
 Abzena Ltd. BiotechnologyHealth Technology Abzena Ltd. engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It offers antibody discover and candidate screening, immunology and immunogenicity assessment, antibody and protein engineering, bio conjugation, custom synthesis of cytotoxic payloads, reagents, and other small molecules, manufacture of payload linkers, development of manufacturing cell lines, and manufacture of biopharmaceuticals. The company was founded by Sunil Shaunak in 2001 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
